# MacKenzie Realty Capital, Inc.: overview MKZR · Nasdaq · CIK 1550913 · [Real estate](/sectors/real-estate.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/mkzr.md) · [Financials](/companies/mkzr/financials.md) · [Filings](/companies/mkzr/filings.md) · [Insiders](/companies/mkzr/insiders.md) Latest reported revenue: [$5.4m](/filings/0001140361-26-037858.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 28, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001140361-26-037858). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [4,952](/filings/0001140361-25-042280.md) | [8,030](/filings/0001140361-26-005766.md) | [4,274](/filings/0001140361-26-021627.md) | [4,804 d](/filings/0001140361-26-037858.md) | [4,539](/filings/0001140361-25-042280.md) | [4,594](/filings/0001140361-26-005766.md) | [5,442](/filings/0001140361-26-021627.md) | [5,433 d](/filings/0001140361-26-037858.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(150.3%)](/filings/0001140361-25-042280.md) | [(56.7%)](/filings/0001140361-26-005766.md) | [(136.4%)](/filings/0001140361-26-021627.md) | [(117.3%) d](/filings/0001140361-26-037858.md) | [(76.8%)](/filings/0001140361-25-042280.md) | [(102.5%)](/filings/0001140361-26-005766.md) | [(46.0%)](/filings/0001140361-26-021627.md) | [(90.5%) d](/filings/0001140361-26-037858.md) | | Net margin | % | [(149.6%)](/filings/0001140361-25-042280.md) | [(55.5%)](/filings/0001140361-26-005766.md) | [(142.6%)](/filings/0001140361-26-021627.md) | [(125.1%) d](/filings/0001140361-26-037858.md) | [(67.1%)](/filings/0001140361-25-042280.md) | [(97.4%)](/filings/0001140361-26-005766.md) | [(18.1%)](/filings/0001140361-26-021627.md) | [(103.4%) d](/filings/0001140361-26-037858.md) | | Diluted EPS | $ per share | [(6.10)](/filings/0001140361-25-042280.md) | [(3.93)](/filings/0001140361-26-005766.md) | [(4.68)](/filings/0001140361-26-021627.md) | not reported | [(2.20)](/filings/0001140361-25-042280.md) | [(2.97)](/filings/0001140361-26-005766.md) | [(0.98)](/filings/0001140361-26-021627.md) | not reported | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [10.4](/filings/0001140361-23-045708.md) | [15.1](/filings/0001140361-24-042226.md) | [15.7](/filings/0001140361-25-036540.md) | [22.1](/filings/0001140361-26-037858.md) | [20.0](/filings/0001140361-26-037858.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(160.2%)](/filings/0001140361-23-045708.md) | [(131.5%)](/filings/0001140361-24-042226.md) | [(63.0%)](/filings/0001140361-25-036540.md) | [(106.4%)](/filings/0001140361-26-037858.md) | [(78.0%)](/filings/0001140361-26-037858.md) | | Net margin | % | [41.3%](/filings/0001140361-23-045708.md) | [(24.4%)](/filings/0001140361-24-042226.md) | [(71.3%)](/filings/0001140361-25-036540.md) | [(108.7%)](/filings/0001140361-26-037858.md) | [(70.6%)](/filings/0001140361-26-037858.md) | | Diluted EPS | $ per share | [0.34](/filings/0001140361-23-045708.md) | [(0.36)](/filings/0001140361-24-042226.md) | [(9.95)](/filings/0001140361-25-036540.md) | [(18.66)](/filings/0001140361-26-037858.md) | [(9.54)](/filings/0001140361-26-037858.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mkzr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Concorde Asset Management, LLC](/funds/1631773.md) | 2026-06-30 | $73.7k | 43,100 | | Not compared | | [Quinn Opportunity Partners LLC](/funds/1633275.md) | 2026-06-30 | $70.8k | 41,396 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $31.5k | 18,401 | | Reduced −21,072 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $31.1k | 18,172 | | Reduced −492 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $29.0k | 16,975 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $13.2k | 7,735 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $6.0k | 3,516 | | Unchanged | | [Farther Finance Advisors, LLC](/funds/1992825.md) | 2026-06-30 | $5.6k | 3,248 | | New +3,248 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $3.8k | 2,215 | | Added +427 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.8k | 2,200 | | New +2,200 | ## Recent filings [All 630 filings](/companies/mkzr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-02 | 16:16 ET | [DEF 14A](/filings/0001550913-26-000036.md) | Proxy statement, period 2026-10-08 | 0001550913-26-000036 | | 2026-10-02 | 15:01 ET | [8-K](/filings/0001550913-26-000034.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001550913-26-000034 | | 2026-09-30 | 17:17 ET | [8-K](/filings/0001550913-26-000031.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001550913-26-000031 | | 2026-09-28 | 17:22 ET | [10-K](/filings/0001140361-26-037858.md) | Annual report, period 2026-06-30 | 0001140361-26-037858 | | 2026-08-11 | 13:53 ET | [SCHEDULE 13D/A](/filings/0001582328-26-000013.md) | Ownership report, active investor, amended | 0001582328-26-000013 | | 2026-08-04 | 17:21 ET | [SCHEDULE 13D/A](/filings/0001582328-26-000009.md) | Ownership report, active investor, amended | 0001582328-26-000009 | | 2026-07-29 | 17:53 ET | [8-K](/filings/0001550913-26-000027.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001550913-26-000027 | | 2026-07-14 | 21:13 ET | [8-K](/filings/0001550913-26-000025.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001550913-26-000025 | | 2026-05-18 | 11:58 ET | [8-K/A](/filings/0001550913-26-000020.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001550913-26-000020 | | 2026-05-15 | 15:30 ET | [8-K](/filings/0001550913-26-000017.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001550913-26-000017 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001140361-26-037858.md), filed Sep 28, 2026. ## Forecast league Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bf1d38b8-5369-4150-98b5-e7e20aeec2fc) ## About the filer - CIK: 1550913 - Tickers: MKZR - Exchange: Nasdaq - SIC code: 6798 Real Estate Investment Trusts - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.